Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ONO 4474

Next Previous
Drug Profile

ONO 4474

Alternative Names: ONO-4474

Latest Information Update: 09 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ono Pharmaceutical
  • Class Analgesics; Anti-inflammatories; Antirheumatics
  • Mechanism of Action Tropomyosin-related kinase antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Pain

Most Recent Events

  • 09 Mar 2021 No development reported - Phase-I/II for Pain (In the elderly, In adults) in Japan (PO) (Ono Pharmaceutical pipeline, March 2021)
  • 19 Oct 2018 Final safety and efficacy data from a phase I/II trial in Pain presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting (ACR/ARHP-2018)
  • 09 Jan 2018 Ono Pharmaceutical terminates the MOTION phase II trial in Pain (In the elderly, In adults) in Denmark, United Kingdom, Hungary, Spain, Poland due to business reasons (PO) (NCT02997696)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top